Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Brain expressed X-linked protein 5 (BEX5) belongs to the BEX gene family, which localizes to the X chromosome and is highly expressed in neural tissues. BEX proteins are intrinsically disordered, serve as signaling mediators, and participate in neuronal development and differentiation, as well as in cell proliferation and apoptosis. Altered expression of BEX family members is associated with various cancers (e.g., glioblastoma, leukemia, breast cancer) and neurodevelopmental processes, suggesting their involvement in disease pathogenesis. BEX5 itself is one of the lesser-studied members, with most functional and disease data derived from studies of BEX1, BEX2, and BEX3, but it is considered part of this broader protein family likely involved in similar biological pathways[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain expressed X-linked protein 5 (BEX5).